Phychem Technologies IPO Opens August 31: ₹14.58 Crore BSE SME Issue to Fund New Machinery and Business Expansion

Phychem Technologies IPO 2026 – BSE SME Issue Coming Next Week

Phychem Technologies Limited is preparing to launch its SME IPO on August 31, 2026, with bidding scheduled to close on September 2.

The company has fixed a price band of ₹51 to ₹54 per share. At the upper price, the issue will raise approximately ₹14.58 crore through up to 27 lakh equity shares. The shares are proposed to list on the BSE SME platform on September 7.

Phychem Technologies IPO Details

The Economic Times currently reports the issue as a fresh issue of 0.27 crore shares, while the original DRHP also confirms an offer size of up to 27 lakh equity shares.

What Does Phychem Technologies Do?

Phychem Technologies operates in a specialised segment of the plastics industry.

The company manufactures specialty rotational moulding powder compounds and also provides related processing and fabrication services from its manufacturing facility at Khatwad, Dindori, Nashik.

Its product portfolio includes:

rotomoulding compounds + antimicrobial powders + foam compounds + rotolining compounds + stone-effect powders + coloured compounds + specialty metallocene grades + PP compounds + customised formulations.

These products are supplied to manufacturers that convert the compounds into finished plastic products.

Where Are Phychem's Products Used?

Rotational moulding compounds have applications across several industries.

The company's materials are supplied in powder or granule form and can ultimately be used in products such as water, fuel and chemical-storage tanks, portable sanitation units, furniture and industrial containers.

This gives Phychem exposure to multiple end-use industries rather than a single consumer market.

Customised Formulations Differentiate the Business

One interesting part of Phychem's model is its ability to create formulations for specific customer requirements.

Instead of selling only standard plastic compounds, the company develops materials with different characteristics such as:

high impact strength + stiffness + gloss + chemical resistance + foam properties + colour + antimicrobial characteristics.

Phychem says it conducts material trials using its laboratory-scale rotational moulding equipment and works with customers through the moulding and processing stage.

This technical-support element can help differentiate the company from suppliers competing mainly on price.

FY2026 Revenue and Profit Show Improvement

Phychem reported another year of growth in FY2026.

FY2026 total income increased approximately 12.5%, while PAT increased around 44% from FY2025.

This means profit growth has been substantially faster than topline growth.

Profitability Has Strengthened

The company's PAT progression has been:

₹1.69 crore → ₹2.84 crore → ₹4.09 crore

between FY2024 and FY2026.

Current FY2026 indicators show:

These figures indicate improved profitability while leverage remains relatively moderate.

IPO Money Will Fund Manufacturing Expansion

A major reason for the IPO is to increase manufacturing capabilities.

Current issue information shows that approximately ₹4.86 crore is intended for plant and machinery, ₹3 crore for debt repayment and another ₹3 crore for working capital.

Use of IPO Proceeds

The allocation toward new machinery is important because Phychem's future growth depends partly on increasing manufacturing capacity.

The basic strategy is:

new machinery → higher capacity → larger production volumes → more customer orders → potential revenue growth.

Debt Repayment Can Strengthen the Balance Sheet

Phychem reported borrowings of approximately ₹5.91 crore in FY2026.

Using around ₹3 crore of IPO proceeds for debt repayment could therefore represent a meaningful reduction relative to existing borrowings.

Potentially, this could lead to:

lower borrowings → lower finance costs → stronger cash generation → improved financial flexibility.

This will be worth monitoring in the company's first post-listing financial results.

Working Capital Will Support Higher Production

Manufacturing businesses need working capital to purchase raw materials, maintain inventory and provide customer credit.

As Phychem increases production, these requirements can also rise.

The planned ₹3 crore working-capital allocation can help fund:

raw materials + inventory + production + receivables.

This becomes particularly important if the company expands faster after installing additional manufacturing equipment.

Rotolining Adds a Specialised Industrial Application

Phychem also manufactures rotolining compounds.

Rotolining uses specially modified polyethylene materials that bond with metal or other surfaces. This can help provide corrosion protection and chemical resistance for industrial equipment such as tanks, vessels, pipes, drums and related components.

This gives the company exposure to industrial applications where product performance can matter more than simply offering the lowest price.

Manufacturing Expansion Is the Main Growth Opportunity

Phychem's stated growth strategy includes expanding its product portfolio, reducing operating costs, increasing its customer base in India and overseas, and increasing manufacturing capacity for its core products.

The IPO therefore arrives at an important point.

If additional machinery allows the company to increase volumes without proportionately increasing fixed costs, operating leverage could improve.

However, new capacity only creates value when customer demand is sufficient to keep that capacity utilised.

Export Markets Provide Another Growth Route

Phychem supplies specialised polymer compounds and has export-oriented capabilities. It is also identified as a One Star Export House by India's Ministry of Commerce and Industry, according to current IPO information.

International expansion can provide access to a larger market for specialised compounds.

But exports also introduce additional factors such as foreign-exchange movements, logistics costs and international competition.

Raw-Material Prices Are an Important Risk

Plastic-compound manufacturing depends heavily on polymer and petrochemical-based raw materials.

Changes in raw-material prices can directly influence manufacturing costs.

The risk is:

raw-material cost rises → selling-price adjustment is delayed → margins come under pressure.

Phychem's ability to manage procurement and pass cost changes to customers will therefore be important for maintaining its improving margins.

SME IPO Requires a Larger Retail Application

Phychem Technologies will list on the BSE SME platform.

The market lot is 2,000 shares, while current application rules show a retail minimum of two lots or 4,000 shares.

At the upper price band:

4,000 shares × ₹54 = ₹2,16,000

SME shares can also experience lower liquidity and greater price volatility after listing compared with larger mainboard companies.

Phychem Technologies IPO GMP

As of the latest available update, Phychem Technologies has no active grey-market premium, with GMP reported at ₹0.

The IPO does not open until August 31, so grey-market sentiment can still change before and during subscription.

GMP is unofficial and should not be treated as a guaranteed listing-price indicator.

Key Strengths of Phychem Technologies

Phychem operates in a specialised manufacturing niche rather than conventional commodity plastic production.

Its product portfolio includes rotomoulding, antimicrobial, foam, rotolining, stone-effect and customised polymer compounds, while its technical capabilities allow it to develop formulations for specific customer applications.

Financial performance has also improved, with total income rising to ₹57.48 crore and PAT reaching ₹4.09 crore in FY2026.

The IPO's use of proceeds is another point to watch because the capital is being directed toward machinery, debt reduction and working capital rather than solely general corporate purposes.

Major Risks

The company remains relatively small, which can make financial performance more sensitive to changes in customer orders or raw-material prices.

Other important risks include customer concentration, polymer-price volatility, manufacturing disruption, competition, working-capital requirements and execution of planned capacity expansion.

The BSE SME listing also brings additional liquidity and volatility risk.

Another important factor is the current ₹0 GMP, which indicates that there is no meaningful unofficial listing premium at present.

What Investors Should Track After Listing

For Phychem Technologies, capacity utilisation and margin sustainability could become two of the most important post-IPO indicators.

Final View on Phychem Technologies IPO

The Phychem Technologies IPO opens on August 31, 2026 and closes on September 2, with a price band of ₹51–₹54. The BSE SME issue will offer up to 27 lakh fresh shares and raise approximately ₹14.58 crore at the upper band.

The company's recent financial trend is positive. FY2026 total income increased to ₹57.48 crore from ₹51.11 crore, while PAT increased to ₹4.09 crore from ₹2.84 crore.

The IPO is particularly focused on strengthening the operating business, with funds planned for new plant and machinery, debt repayment and working capital.